What RenovoRx Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 13 |
| Sells | 0 | 0 |
| Total trades | 1 | 16 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 80,000 | 402,600 |
| Disposed | 0 | 0 |
| Net activity | +80,000 | +402,600 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Voll Mark | Chief Financial Officer | Sep 10 | Grant / award · A | +80,000 | — | — | 222,380 |
| Voll Mark | Chief Financial Officer | May 19 | Open-market buy · P | +25,000 | $0.79 | +$19.7K | 142,380 |
| Voll Mark | Chief Financial Officer | Apr 03 | Grant / award · A | +80,000 | — | — | 117,380 |
| Voll Mark | Chief Financial Officer | Mar 25 | Grant / award · A | +12,380 | — | — | 37,380 |
| Voll Mark | Chief Financial Officer | Mar 20 | Open-market buy · P | +97,200 | — | — | 97,200 |
| Bagai Shaun | Chief Executive Officer | Mar 20 | Open-market buy · P | +24,300 | — | — | 313,357 |
| Marton Laurence | Director | Mar 20 | Open-market buy · P | +9,720 | — | — | 9,720 |
| Agah Ramtin | Chief Medical Officer | Jan 21 | Open-market buy · P | +10,000 | $1.00 | +$9.98K | 798,460 |
| Agah Ramtin | Chief Medical Officer | Dec 31 | Open-market buy · P | +9,795 | $0.86 | +$8.42K | 788,460 |
| Agah Ramtin | Chief Medical Officer | Dec 30 | Open-market buy · P | +205 | $0.83 | +$169 | 778,665 |
| Bagai Shaun | Chief Executive Officer | Dec 18 | Open-market buy · P | +5,000 | $0.90 | +$4.51K | 340,040 |
| Bagai Shaun | Chief Executive Officer | Dec 17 | Open-market buy · P | +5,000 | $0.85 | +$4.26K | 335,040 |
| Agah Ramtin | Chief Medical Officer | Dec 16 | Open-market buy · P | +12,000 | $0.85 | +$10.2K | 778,460 |
| Agah Ramtin | Chief Medical Officer | Dec 05 | Open-market buy · P | +10,000 | $0.96 | +$9.6K | 766,460 |
| Agah Ramtin | Chief Medical Officer | Nov 24 | Open-market buy · P | +12,000 | $0.80 | +$9.6K | 756,460 |
| Agah Ramtin | Chief Medical Officer | Nov 21 | Open-market buy · P | +10,000 | $0.80 | +$8K | 744,460 |
| Bagai Shaun | Chief Executive Officer | Aug 25 | Open-market buy · P | +5,000 | $0.91 | +$4.55K | 330,040 |
| Bagai Shaun | Chief Executive Officer | Aug 22 | Open-market buy · P | +5,000 | $0.95 | +$4.75K | 325,040 |
| Agah Ramtin | Chief Medical Officer | Jun 05 | Open-market buy · P | +21,000 | $1.40 | +$29.4K | 734,460 |
| Marton Laurence | Director | May 02 | Exercise / conversion · M | +20,480 | $0.15 | +$3.07K | 66,164 |
Loading...
